drugset / Trial / NCT01762397

A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of PMK-S005 After Oral Administration in Healthy Male Volunteers

NCT01762397 ↗

Phase 1 Completed 37 enrolled PharmaKing
RandomizedParallel-groupDouble-blindTreatment

Summary

The Purpose of a randomized, double-blind, placebo-controlled, single-dose, dose-escalation clinical trial is to explore investigate the safety, tolerability, pharmacokinetics, and food effect of PMK-S005 after oral administration in healthy male volunteers.

Timeline

Start
2012-12
Primary completion
2013-05
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject PMK-S005 Unknown — Oral

Indications